Targeting human urinary metabolome by LC–MS/MS: a review

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Emwas A-HM. The strengths and weaknesses of NMR spectroscopy and mass spectrometry with particular focus on metabolomics research. In: Metabonomics: Methods and Protocols. Bjerrum JT (Ed.). Springer, NY, USA, 161–193 (2015).
  Google Scholar
• 2 Bouatra S, Aziat F, Mandal R et al. The human urine metabolome. PLoS ONE 8(9), 73076 (2013). •• Extensive analysis of human urine employing six different analytical platforms and covering hundreds of different analytes.
  Medline CASGoogle Scholar
• 3 HMDB. www.hmdb.ca.
  Google Scholar
• 4 Wishart DS, Feunang YD, Marcu A et al. HMDB 4.0: the human metabolome database for 2018. Nucleic Acids Res. 46(D1), D608–D617 (2018).
  Medline CASGoogle Scholar
• 5 Wishart DS. Quantitative metabolomics using NMR. Trends Analyt. Chem. 27(3), 228–237 (2008).
  CASGoogle Scholar
• 6 Beckonert O, Keun HC, Ebbels TM et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat. Protoc. 2(11), 2692–2703 (2007).
  Medline CASGoogle Scholar
• 7 Zhang T, Watson DG. A short review of applications of liquid chromatography mass spectrometry based metabolomics techniques to the analysis of human urine. Analyst 140(9), 2907–2915 (2015). • Short review article focused on recent applications of urinary metabolomic analysis using LC–MS.
  Medline CASGoogle Scholar
• 8 Stankovic AK, Dilauri E. Quality improvements in the preanalytical phase: focus on urine specimen workflow. Clin. Lab. Med. 28(2), 339–350 (2008).
  MedlineGoogle Scholar
• 9 Ferraz RRN, Baxmann AC, Ferreira LG et al. Preservation of urine samples for metabolic evaluation of stone-forming patients. Urol. Res. 34(5), 329–337 (2006).
  MedlineGoogle Scholar
• 10 Delanghe J, Speeckaert M. Preanalytical requirements of urinalysis. Biochem. Medica 24(1), 89–104 (2014).
  Medline CASGoogle Scholar
• 11 Marcos J, Pol M, Fabregat A et al. Urinary cysteinyl progestogens: occurrence and origin. J. Steroid Biochem. Mol. Biol. 152(Suppl. C), 53–61 (2015).
  Medline CASGoogle Scholar
• 12 Papantoniou K, Pozo OJ, Espinosa A et al. Increased and mistimed sex hormone production in night shift workers. Cancer Epidemiol. Biomarkers Prev. 24(5), 854–863 (2015).
  Medline CASGoogle Scholar
• 13 Remer T, Boye KR, Hartmann MF, Wudy SA. Urinary markers of adrenarche: reference values in healthy subjects, aged 3–18 years. J. Clin. Endocrinol. Metab. 90(4), 2015–2021 (2005).
  Medline CASGoogle Scholar
• 14 Esko T, Hirschhorn JN, Feldman HA et al. Metabolomic profiles as reliable biomarkers of dietary composition. Am. J. Clin. Nutr. 105(3), 547–554 (2017).
  Medline CASGoogle Scholar
• 15 Guasch-Ferré M, Bhupathiraju SN, Hu FB. Use of metabolomics in improving assessment of dietary intake. Clin. Chem. 64(1), 82–98 (2018).
  Medline CASGoogle Scholar
• 16 Thompson DK, Sloane R, Bain JR et al. Daily variation of serum acylcarnitines and amino acids. Metabolomics 8(4), 556–565 (2012).
  Medline CASGoogle Scholar
• 17 Dunn WB, Broadhurst D, Ellis DI et al. A GC-TOF-MS study of the stability of serum and urine metabolomes during the UK Biobank sample collection and preparation protocols. Int. J. Epidemiol. 37(Suppl. 1), i23–i30 (2008).
  MedlineGoogle Scholar
• 18 Laparre J, Kaabia Z, Mooney M et al. Impact of storage conditions on the urinary metabolomics fingerprint. Anal. Chim. Acta 951(Suppl. C), 99–107 (2017).
  Medline CASGoogle Scholar
• 19 Tsivou M, Livadara D, Georgakopoulos DG, Koupparis MA, Atta-Politou J, Georgakopoulos CG. Stabilization of human urine doping control samples. Anal. Biochem. 388(2), 179–191 (2009).
  Medline CASGoogle Scholar
• 20 Vuckovic D. Current trends and challenges in sample preparation for global metabolomics using liquid chromatography–mass spectrometry. Anal. Bioanal. Chem. 403(6), 1523–1548 (2012).
  Medline CASGoogle Scholar
• 21 Deventer K, Pozo OJ, Verstraete AG, Van Eenoo P. Dilute-and-shoot-liquid chromatography-mass spectrometry for urine analysis in doping control and analytical toxicology. Trends Analyt. Chem. 55(Suppl. C), 1–13 (2014).
  CASGoogle Scholar
• 22 Fernández-Peralbo MA, Luque De Castro MD. Preparation of urine samples prior to targeted or untargeted metabolomics mass-spectrometry analysis. Trends Analyt. Chem. 41(Suppl. C), 75–85 (2012).
  CASGoogle Scholar
• 23 Pesek JJ, Matyska MT, Loo JA, Fischer SM, Sana TR. Analysis of hydrophilic metabolites in physiological fluids by HPLC–MS using a silica hydride-based stationary phase. J. Sep. Sci. 32(13), 2200–2208 (2009).
  Medline CASGoogle Scholar
• 24 Bernini P, Bertini I, Luchinat C, Nincheri P, Staderini S, Turano P. Standard operating procedures for pre-analytical handling of blood and urine for metabolomic studies and biobanks. J. Biomol. NMR 49(3), 231–243 (2011).
  Medline CASGoogle Scholar
• 25 Pluym N, Gilch G, Scherer G, Scherer M. Analysis of 18 urinary mercapturic acids by two high-throughput multiplex-LC–MS/MS methods. Anal. Bioanal. Chem. 407(18), 5463–5476 (2015).
  Medline CASGoogle Scholar
• 26 Yin S, Su M, Xie G et al. Factors affecting separation and detection of bile acids by liquid chromatography coupled with mass spectrometry in negative mode. Anal. Bioanal. Chem. 409(23), 5533–5545 (2017).
  Medline CASGoogle Scholar
• 27 Khamis MM, Adamko DJ, El-Aneed A. Mass spectrometric based approaches in urine metabolomics and biomarker discovery. Mass Spectrom. Rev. 36(2), 115–134 (2017).
  Medline CASGoogle Scholar
• 28 Shackleton CH. Profiling steroid hormones and urinary steroids. J. Chromatogr. 379, 91–156 (1986). •• Excellent revision about steroidomics made before metabolomics era.
  Medline CASGoogle Scholar
• 29 Vuorensola K, Siren H, Karjalainen U. Determination of dopamine and methoxycatecholamines in patient urine by liquid chromatography with electrochemical detection and by capillary electrophoresis coupled with spectrophotometry and mass spectrometry. J. Chromatogr. B 788(2), 277–289 (2003).
  Medline CASGoogle Scholar
• 30 Nováková L, Vlčková H. A review of current trends and advances in modern bio-analytical methods: chromatography and sample preparation. Anal. Chim. Acta 656(1), 8–35 (2009).
  Medline CASGoogle Scholar
• 31 Chambers E, Wagrowski-Diehl DM, Lu Z, Mazzeo JR. Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analyses. J. Chromatogr. B 852(1–2), 22–34 (2007).
  Medline CASGoogle Scholar
• 32 Deng P, Zhan Y, Chen X, Zhong D. Derivatization methods for quantitative bioanalysis by LC–MS/MS. Bioanalysis 4(1), 49–69 (2011).
  Google Scholar
• 33 Al Kadhi O, Melchini A, Mithen R, Saha S. Development of a LC–MS/MS method for the simultaneous detection of tricarboxylic acid cycle intermediates in a range of biological matrices. J. Anal. Methods Chem. 2017, 5391832 (2017).
  MedlineGoogle Scholar
• 34 Tan B, Lu Z, Dong S, Zhao G, Kuo MS. Derivatization of the tricarboxylic acid intermediates with O-benzylhydroxylamine for liquid chromatography-tandem mass spectrometry detection. Anal. Biochem. 465, 134–147 (2014).
  Medline CASGoogle Scholar
• 35 Chokkathukalam A, Kim D-H, Barrett MP, Breitling R, Creek DJ. Stable isotope-labeling studies in metabolomics: new insights into structure and dynamics of metabolic networks. Bioanalysis 6(4), 511–524 (2014).
  CASGoogle Scholar
• 36 Guo K, Li L. Differential 12C-/13C-isotope dansylation labeling and fast liquid chromatography/mass spectrometry for absolute and relative quantification of the metabolome. Anal. Chem. 81(10), 3919–3932 (2009).
  Medline CASGoogle Scholar
• 37 Zhou R, Guo K, Li L. 5-Diethylamino-naphthalene-1-sulfonyl Chloride (DensCl): a novel triplex isotope labeling reagent for quantitative metabolome analysis by liquid chromatography mass spectrometry. Anal. Chem. 85(23), 11532–11539 (2013).
  Medline CASGoogle Scholar
• 38 Guo K, Li L. High-performance isotope labeling for profiling carboxylic acid-containing metabolites in biofluids by mass spectrometry. Anal. Chem. 82(21), 8789–8793 (2010).
  Medline CASGoogle Scholar
• 39 Liu P, Huang YQ, Cai WJ, Yuan BF, Feng YQ. Profiling of thiol-containing compounds by stable isotope labeling double precursor ion scan mass spectrometry. Anal. Chem. 86(19), 9765–9773 (2014).
  Medline CASGoogle Scholar
• 40 Tang DQ, Zou L, Yin XX, Ong CN. HILIC-MS for metabolomics: an attractive and complementary approach to RPLC-MS. Mass Spectrom. Rev. 35(5), 574–600 (2016). • Revision of the use of hydrophilic interaction chromatography in metabolomics containing numerous examples of different families of metabolites.
  Medline CASGoogle Scholar
• 41 Mcleod MD, Waller CC, Esquivel A et al. Constant ion loss method for the untargeted detection of bis-sulfate metabolites. Anal. Chem. 89(3), 1602–1609 (2017).
  Medline CASGoogle Scholar
• 42 Forcisi S, Moritz F, Kanawati B, Tziotis D, Lehmann R, Schmitt-Kopplin P. Liquid chromatography-mass spectrometry in metabolomics research: mass analyzers in ultra high pressure liquid chromatography coupling. J. Chromatogr. A 1292, 51–65 (2013).
  Medline CASGoogle Scholar
• 43 An Z, Chen Y, Zhang R et al. Integrated ionization approach for RRLC−MS/MS-based metabonomics: finding potential biomarkers for lung cancer. J. Proteome Res. 9(8), 4071–4081 (2010).
  Medline CASGoogle Scholar
• 44 Keski-Hynnilä H, Kurkela M, Elovaara E et al. Comparison of electrospray, atmospheric pressure chemical ionization, and atmospheric pressure photoionization in the identification of apomorphine, dobutamine, and entacapone Phase II metabolites in biological samples. Anal. Chem. 74(14), 3449–3457 (2002).
  MedlineGoogle Scholar
• 45 Mcculloch RD, Robb DB. Field-free atmospheric pressure photoionization–liquid chromatography–mass spectrometry for the analysis of steroids within complex biological matrices. Anal. Chem. 89(7), 4169–4176 (2017).
  Medline CASGoogle Scholar
• 46 Junot C, Fenaille F, Colsch B, Becher F. High resolution mass spectrometry based techniques at the crossroads of metabolic pathways. Mass Spectrom. Rev. 33(6), 471–500 (2014).
  Medline CASGoogle Scholar
• 47 Pozo OJ, Deventer K, Van Eenoo P, Delbeke FT. Presence of endogenous interferences in the urinary detection of selected anabolic steroids by liquid chromatography/electrospray tandem mass spectrometry. Rapid Commun. Mass Spectrom. 21(17), 2785–2796 (2007).
  Medline CASGoogle Scholar
• 48 Matuszewski BK, Constanzer ML, Chavez-Eng CM. Matrix effect in quantitative LC/MS/MS analyses of biological fluids: a method for determination of finasteride in human plasma at picogram per milliliter concentrations. Anal. Chem. 70(5), 882–889 (1998).
  Medline CASGoogle Scholar
• 49 Stokvis E, Rosing H, Beijnen JH. Stable isotopically labeled internal standards in quantitative bioanalysis using liquid chromatography/mass spectrometry: necessity or not? Rapid Commun. Mass Spectrom. 19(3), 401–407 (2005).
  Medline CASGoogle Scholar
• 50 FDA guidelines for Industry. Analytical procedures and methods validation for drugs and biologics. www.fda.gov/downloads/drugs/guidances/ucm386366.pdf.
  Google Scholar
• 51 European Medicines Agency. Guideline on Bioanalytical Method Validation. www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500109686.pdf.
  Google Scholar
• 52 Badoud F, Grata E, Boccard J et al. Quantification of glucuronidated and sulfated steroids in human urine by ultra-high pressure liquid chromatography quadrupole time-of-flight mass spectrometry. Anal. Bioanal. Chem. 400(2), 503–516 (2011).
  Medline CASGoogle Scholar
• 53 Jemal M, Schuster A, Whigan DB. Liquid chromatography/tandem mass spectrometry methods for quantitation of mevalonic acid in human plasma and urine: method validation, demonstration of using a surrogate analyte, and demonstration of unacceptable matrix effect in spite of use of a stable isotope analog internal standard. Rapid Commun. Mass Spectrom. 17(15), 1723–1734 (2003).
  Medline CASGoogle Scholar
• 54 Marcos J, Renau N, Valverde O et al. Targeting tryptophan and tyrosine metabolism by liquid chromatography tandem mass spectrometry. J. Chromatogr. A 1434(Suppl. C), 91–101 (2016).
  Medline CASGoogle Scholar
• 55 Warrack BM, Hnatyshyn S, Ott KH et al. Normalization strategies for metabonomic analysis of urine samples. J. Chromatogr. B 877(5–6), 547–552 (2009).
  Medline CASGoogle Scholar
• 56 Daskalaki E, Blackburn G, Kalna G, Zhang T, Anthony N, Watson DG. A study of the effects of exercise on the urinary metabolome using normalisation to individual metabolic output. Metabolites 5(1), 119–139 (2015).
  Medline CASGoogle Scholar
• 57 Ryan D, Robards K, Prenzler PD, Kendall M. Recent and potential developments in the analysis of urine: a review. Anal. Chim. Acta 684(1–2), 8–20 (2011). •• Summary of many aspects that have to be considered when analyzing urine samples, including a nice description about the challenges of normalization of metabolite concentrations.
  Medline CASGoogle Scholar
• 58 Edmands WM, Ferrari P, Scalbert A. Normalization to specific gravity prior to analysis improves information recovery from high resolution mass spectrometry metabolomic profiles of human urine. Anal. Chem. 86(21), 10925–10931 (2014).
  Medline CASGoogle Scholar
• 59 Boudonck KJ, Rose DJ, Karoly ED, Lee DP, Lawton KA, Lapinskas PJ. Metabolomics for early detection of drug-induced kidney injury: review of the current status. Bioanalysis 1(9), 1645–1663 (2009).
  CASGoogle Scholar
• 60 Ogawa T, Matson WR, Beal MF et al. Kynurenine pathway abnormalities in Parkinson's disease. Neurology 42(9), 1702–1706 (1992).
  Medline CASGoogle Scholar
• 61 Palermo M, Shackleton CH, Mantero F, Stewart PM. Urinary free cortisone and the assessment of 11 β-hydroxysteroid dehydrogenase activity in man. Clin. Endocrinol. 45(5), 605–611 (1996).
  Medline CASGoogle Scholar
• 62 Shackleton CH, Marcos J, Palomaki GE et al. Dehydrosteroid measurements in maternal urine or serum for the prenatal diagnosis of Smith-Lemli-Opitz syndrome (SLOS). Am. J. Med. Genet. A 143A(18), 2129–2136 (2007).
  MedlineGoogle Scholar
• 63 Wu G. Amino acids: metabolism, functions, and nutrition. Amino Acids 37(1), 1–17 (2009).
  MedlineGoogle Scholar
• 64 Jones LL, Mcdonald DA, Borum PR. Acylcarnitines: role in brain. Prog. Lipid Res. 49(1), 61–75 (2010).
  Medline CASGoogle Scholar
• 65 McGraw-Hill Medical. The online metabolic and molecular bases of inherited disease. https://ommbid.mhmedical.com/book.aspx?bookID=971.
  Google Scholar
• 66 Wang TJ, Larson MG, Vasan RS et al. Metabolite profiles and the risk of developing diabetes. Nat. Med. 17(4), 448–453 (2011).
  MedlineGoogle Scholar
• 67 Meesters RJW. Bioanalytical LC separation techniques for quantitative analysis of free amino acids in human plasma. Bioanalysis 5(4), 495–512 (2013).
  CASGoogle Scholar
• 68 Le A, Ng A, Kwan T, Cusmano-Ozog K, Cowan TM. A rapid, sensitive method for quantitative analysis of underivatized amino acids by liquid chromatography–tandem mass spectrometry (LC–MS/MS). J. Chromatogr. B 944(Suppl. C), 166–174 (2014).
  Medline CASGoogle Scholar
• 69 National Metabolic Biochemistry Network. www.metbio.net/metbioguidelines.asp.
  Google Scholar
• 70 Kaspar H, Dettmer K, Chan Q et al. Urinary amino acid analysis: a comparison of iTRAQ^®–LC–MS/MS, GC–MS, and amino acid analyzer. J. Chromatogr. B 877(20), 1838–1846 (2009).
  Medline CASGoogle Scholar
• 71 Rotter M, Brandmaier S, Prehn C et al. Stability of targeted metabolite profiles of urine samples under different storage conditions. Metabolomics 13(1), 4 (2017). • Detailed study about the influence of storage condition on the urinary metabolome, with special emphasis in amino acids.
  MedlineGoogle Scholar
• 72 Gray N, Plumb R. A validated method for the quantification of amino acids in mammalian urine. Waters Corporation Application note 2016. www.waters.com.
  Google Scholar
• 73 Qu J, Wang Y, Luo G, Wu Z, Yang C. Validated quantitation of underivatized amino acids in human blood samples by volatile ion-pair reversed-phase liquid chromatography coupled to isotope dilution tandem mass spectrometry. Anal. Chem. 74(9), 2034–2040 (2002).
  Medline CASGoogle Scholar
• 74 Waterval WAH, Scheijen JLJM, Ortmans-Ploemen MMJC, Habets-Van Der Poel CD, Bierau J. Quantitative UPLC–MS/MS analysis of underivatised amino acids in body fluids is a reliable tool for the diagnosis and follow-up of patients with inborn errors of metabolism. Clin. Chim. Acta 407(1), 36–42 (2009).
  Medline CASGoogle Scholar
• 75 Imtakt. Intrada amino acids separation column for LC–MS. www.imtaktusa.com.
  Google Scholar
• 76 Schooneman MG, Vaz FM, Houten SM, Soeters MR. Acylcarnitines. Diabetes 62(1), 1–8 (2013).
  Medline CASGoogle Scholar
• 77 Minkler PE, Stoll MSK, Ingalls ST, Kerner J, Hoppel CL. Validated method for the quantification of free and total carnitine, butyrobetaine, and acylcarnitines in biological samples. Anal. Chem. 87(17), 8994–9001 (2015).
  Medline CASGoogle Scholar
• 78 Minkler PE, Stoll MSK, Ingalls ST, Kerner J, Hoppel CL. Quantitative acylcarnitine determination by UHPLC–MS/MS – going beyond tandem MS acylcarnitine ‘profiles’. Mol. Gen. Metab. 116(4), 231–241 (2015).
  Medline CASGoogle Scholar
• 79 Minkler PE, Stoll MSK, Ingalls ST, Hoppel CL. Selective and accurate C5 acylcarnitine quantitation by UHPLC–MS/MS: distinguishing true isovaleric acidemia from pivalate derived interference. J. Chromatogr. B 1061–1062(Suppl. C), 128–133 (2017).
  Medline CASGoogle Scholar
• 80 Bassi R, Niewczas MA, Biancone L et al. Metabolomic profiling in individuals with a failing kidney allograft. PLoS ONE 12(1), e0169077 (2017).
  MedlineGoogle Scholar
• 81 Dong S, Zhan Z-Y, Cao H-Y et al. Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver disease. World J. Gastroenterol. 23(15), 2771–2784 (2017).
  Medline CASGoogle Scholar
• 82 Fang L, Gu C, Liu X et al. Metabolomics study on primary dysmenorrhea patients during the luteal regression stage based on ultra performance liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry. Mol. Med. Rep. 15(3), 1043–1050 (2017).
  Medline CASGoogle Scholar
• 83 Abe K, Suzuki H, Maekawa M, Shimada M, Yamaguchi H, Mano N. Matrix effect–corrected liquid chromatography/tandem mass-spectrometric method for determining acylcarnitines in human urine. Clin. Chim. Acta 468(Suppl. C), 187–194 (2017).
  Medline CASGoogle Scholar
• 84 Li X, Li S, Kellermann G. Pre-analytical and analytical validations and clinical applications of a miniaturized, simple and cost-effective solid phase extraction combined with LC–MS/MS for the simultaneous determination of catecholamines and metanephrines in spot urine samples. Talanta 159(Suppl. C), 238–247 (2016).
  Medline CASGoogle Scholar
• 85 Boomsma F, Alberts G, Van Eijk L, Man in 't Veld AJ, Schalekamp MA. Optimal collection and storage conditions for catecholamine measurements in human plasma and urine. Clin. Chem. 39(12), 2503–2508 (1993).
  Medline CASGoogle Scholar
• 86 Peitzsch M, Pelzel D, Lattke P, Siegert G, Eisenhofer G. Preservation of urine free catecholamines and their free O-methylated metabolites with citric acid as an alternative to hydrochloric acid for LC–MS/MS-based analyses. Clin. Chem. Lab. Med. 54(1), 37 (2016).
  Medline CASGoogle Scholar
• 87 Bergmann ML, Sadjadi S, Schmedes A. Analysis of catecholamines in urine by unique LC/MS suitable ion-pairing chromatography. J. Chromatogr. B 1057(Suppl. C), 118–123 (2017).
  Medline CASGoogle Scholar
• 88 Shen Y, Cheng L, Guan Q, Li H, Lu J, Wang X. Development and validation of a liquid chromatography tandem mass spectrometry method for the measurement of urinary catecholamines in diagnosis of pheochromocytoma. Biomed. Chromatogr. 31(11), e4003–e4003 (2017).
  Google Scholar
• 89 Woo HI, Yang JS, Oh HJ et al. A simple and rapid analytical method based on solid-phase extraction and liquid chromatography–tandem mass spectrometry for the simultaneous determination of free catecholamines and metanephrines in urine and its application to routine clinical analysis. Clin. Biochem. 49(7), 573–579 (2016).
  Medline CASGoogle Scholar
• 90 Diniz MER, Vilhena LS, Paulo BP, Barbosa TCC, Mateo EC. Simultaneous determination of catecholamines and metanephrines in urine by liquid chromatography electrospray ionization tandem mass spectrometry: successful clinical application. J. Braz. Chem. Soc. 26, 1684–1691 (2015).
  CASGoogle Scholar
• 91 Gabler J, Wang S. Quantification of metanephrine and normetanephrine in urine using liquid chromatography-tandem mass spectrometry. In: Clinical Applications of Mass Spectrometry in Biomolecular Analysis: Methods and Protocols. Garg U (Ed.). Springer, NY, USA, 149–157 (2016).
  Google Scholar
• 92 Li X, Li S, Wynveen P, Mork K, Kellermann G. Development and validation of a specific and sensitive LC–MS/MS method for quantification of urinary catecholamines and application in biological variation studies. Anal. Bioanal. Chem. 406(28), 7287–7297 (2014).
  Medline CASGoogle Scholar
• 93 Konieczna L, Roszkowska A, Niedźwiecki M, Bączek T. Hydrophilic interaction chromatography combined with dispersive liquid–liquid microextraction as a preconcentration tool for the simultaneous determination of the panel of underivatized neurotransmitters in human urine samples. J. Chromatogr. A 1431(Suppl. C), 111–121 (2016).
  Medline CASGoogle Scholar
• 94 Ghosh A, Nishtala K. Biofluid lipidome: a source for potential diagnostic biomarkers. Clin. Transl. Med. 6, 22 (2017).
  MedlineGoogle Scholar
• 95 Graessler J, Mehnert CS, Schulte KM et al. Urinary Lipidomics: evidence for multiple sources and sexual dimorphism in healthy individuals. Pharmacogenomics J. doi:10.1038/tpj.2017.24 (2017) (Epub ahead of print).
  MedlineGoogle Scholar
• 96 Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37(8), 911–917 (1959).
  Medline CASGoogle Scholar
• 97 Folch J, Lees M, Stanley GHS. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226(1), 497–509 (1957).
  Medline CASGoogle Scholar
• 98 Matyash V, Liebisch G, Kurzchalia TV, Shevchenko A, Schwudke D. Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J. Lip. Res. 49(5), 1137–1146 (2008).
  Medline CASGoogle Scholar
• 99 Tipthara P, Thongboonkerd V. Differential human urinary lipid profiles using various lipid-extraction protocols: MALDI-TOF and LIFT-TOF/TOF analyses. Sci. Rep. 6, 33756 (2016).
  Medline CASGoogle Scholar
• 100 Breitkopf SB, Ricoult SJH, Yuan M et al. A relative quantitative positive/negative ion switching method for untargeted lipidomics via high resolution LC–MS/MS from any biological source. Metabolomics 13(3), 30 (2017).
  MedlineGoogle Scholar
• 101 Byeon SK, Lee JY, Lee J-S, Moon MH. Lipidomic profiling of plasma and urine from patients with Gaucher disease during enzyme replacement therapy by nanoflow liquid chromatography–tandem mass spectrometry. J. Chromatogr. A 1381(Suppl. C), 132–139 (2015).
  Medline CASGoogle Scholar
• 102 Gorden DL, Myers DS, Ivanova PT et al. Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. J. Lip. Res. 56(3), 722–736 (2015). •• Nice example of a combination of differently targeted lipidomic analyses in several matrices (liver, plasma and urine) with a potential application to the diagnostics of nonalcoholic fatty liver disease.
  Medline CASGoogle Scholar
• 103 Rockwell HE, Gao F, Chen EY et al. Dynamic assessment of functional lipidomic analysis in human urine. Lipids 51(7), 875–886 (2016).
  Medline CASGoogle Scholar
• 104 Cho K, Moon JS, Kang JH et al. Combined untargeted and targeted metabolomic profiling reveals urinary biomarkers for discriminating obese from normal-weight adolescents. Pediatr. Obes. 12(2), 93–101 (2017).
  Medline CASGoogle Scholar
• 105 Fu J, Schoeman JC, Harms AC et al. Metabolomics profiling of the free and total oxidised lipids in urine by LC–MS/MS: application in patients with rheumatoid arthritis. Anal. Bioanal. Chem. 408(23), 6307–6319 (2016).
  Medline CASGoogle Scholar
• 106 Wang M, Wang C, Han RH, Han X. Novel advances in shotgun lipidomics for biology and medicine. Prog. Lipid Res. 61, 83–108 (2016).
  Medline CASGoogle Scholar
• 107 Zhao Y-Y, Vaziri ND, Lin R-C. Chapter six – lipidomics: new insight into kidney disease. In: Advances in Clinical Chemistry. Makowski GS (Ed.). Elsevier, Amsterdam, The Netherlands, 153–175 (2015).
  Google Scholar
• 108 Ovčačíková M, Lísa M, Cífková E, Holčapek M. Retention behavior of lipids in reversed-phase ultrahigh-performance liquid chromatography–electrospray ionization mass spectrometry. J. Chromatogr. A 1450(Suppl. C), 76–85 (2016).
  Medline CASGoogle Scholar
• 109 Lueke AJ, Meeusen JW, Donato LJ, Gray AV, Butterfield JH, Saenger AK. Analytical and clinical validation of an LC–MS/MS method for urine leukotriene E4: a marker of systemic mastocytosis. Clin. Biochem. 49(13), 979–982 (2016).
  Medline CASGoogle Scholar
• 110 Xiao Y, Fu X, Pattengale P, Dien Bard J, Xu Y-K, O'Gorman MR. A sensitive LC–MS/MS method for the quantification of urinary 8-iso-prostaglandin F2α (8-iso-PGF2α) including pediatric reference interval. Clin. Chim. Acta 460(Suppl. C), 128–134 (2016).
  Medline CASGoogle Scholar
• 111 Peng M, Liu L, Jiang M et al. Measurement of free carnitine and acylcarnitines in plasma by HILIC-ESI-MS/MS without derivatization. J. Chromatogr. B 932(Suppl. C), 12–18 (2013).
  Medline CASGoogle Scholar
• 112 Koivusalo M, Haimi P, Heikinheimo L, Kostiainen R, Somerharju P. Quantitative determination of phospholipid compositions by ESI-MS: effects of acyl chain length, unsaturation, and lipid concentration on instrument response. J. Lip. Res. 42(4), 663–672 (2001).
  MedlineGoogle Scholar
• 113 Biocrates. List of isobaric and isomeric lipids. www.biocrates.com/images/List-of-Isobaric-and-Isomeric-Lipid-Species.pdf.
  Google Scholar
• 114 Yang K, Han X. Lipidomics: techniques, applications, and outcomes related to biomedical sciences. Trends Biochem. Sci. 41(11), 954–969 (2016).
  Medline CASGoogle Scholar
• 115 Okemoto K, Maekawa K, Tajima Y, Tohkin M, Saito Y. Cross-classification of human urinary lipidome by sex, age, and body mass index. PLoS ONE 11(12), e0168188 (2016).
  MedlineGoogle Scholar
• 116 Jeanneret F, Tonoli D, Rossier MF, Saugy M, Boccard J, Rudaz S. Evaluation of steroidomics by liquid chromatography hyphenated to mass spectrometry as a powerful analytical strategy for measuring human steroid perturbations. J. Chromatogr. A 1430, 97–112 (2016).
  Medline CASGoogle Scholar
• 117 Sjovall J. Fifty years with bile acids and steroids in health and disease. Lipids 39(8), 703–722 (2004). • Nice historic perspective about steroid measurements in health and disease.
  MedlineGoogle Scholar
• 118 Homer N, Kothiya S, Rutter A, Walker BR, Andrew R. Gas chromatography tandem mass spectrometry offers advantages for urinary steroids analysis. Anal. Biochem. 538, 34–37 (2017).
  Medline CASGoogle Scholar
• 119 Catlin DH, Sekera MH, Ahrens BD, Starcevic B, Chang YC, Hatton CK. Tetrahydrogestrinone: discovery, synthesis, and detection in urine. Rapid Commun. Mass Spectrom. 18(12), 1245–1249 (2004).
  Medline CASGoogle Scholar
• 120 Gomez C, Fabregat A, Pozo ÓJ, Marcos J, Segura J, Ventura R. Analytical strategies based on mass spectrometric techniques for the study of steroid metabolism. Trends Analyt. Chem. 53(Suppl. C), 106–116 (2014).
  CASGoogle Scholar
• 121 Penning TM, Lee S-H, Jin Y, Gutierrez A, Blair IA. Liquid-chromatography mass spectrometry (LC–MS) of steroid hormone metabolites and its applications. J. Steroid Biochem. Mol. Biol. 121(3–5), 546–555 (2010).
  Medline CASGoogle Scholar
• 122 Jerjes WK, Cleare AJ, Peters TJ, Taylor NF. Circadian rhythm of urinary steroid metabolites. Ann. Clin. Biochem. 43(Pt 4), 287–294 (2006).
  Medline CASGoogle Scholar
• 123 Pozo OJ, Marcos J, Fabregat A et al. Adrenal hormonal imbalance in acute intermittent porphyria patients: results of a case control study. Orphanet J. Rare Dis. 9, 54– (2014).
  MedlineGoogle Scholar
• 124 De La Torre R, De La Torre X, AlíA C, Segura J, Baró T, Torres-RodríGuez JM. Changes in androgenic steroid profile due to urine contamination by microorganisms: a prospective study in the context of doping control. Anal. Biochem. 289(2), 116–123 (2001).
  Medline CASGoogle Scholar
• 125 Tsivou M, Livadara D, Georgakopoulos DG, Koupparis MA, Atta-Politou J, Georgakopoulos CG. Stabilization of human urine doping control samples: II. microbial degradation of steroids. Anal. Biochem. 388(1), 146–154 (2009).
  Medline CASGoogle Scholar
• 126 Tsivou M, Giannadaki E, Hooghe F et al. Doping control container for urine stabilization: a pilot study. Drug Test. Anal. 9(5), 699–712 (2017).
  Medline CASGoogle Scholar
• 127 Schanzer W, Opfermann G, Donike M. 17-Epimerization of 17 α-methyl anabolic steroids in humans: metabolism and synthesis of 17 α-hydroxy-17 β-methyl steroids. Steroids 57(11), 537–550 (1992).
  Medline CASGoogle Scholar
• 128 Fabregat A, Marcos J, Segura J, Ventura R, Pozo OJ. Factors affecting urinary excretion of testosterone metabolites conjugated with cysteine. Drug Test. Anal. 8(1), 110–119 (2016).
  MedlineGoogle Scholar
• 129 Schanzer W. Metabolism of anabolic androgenic steroids. Clin. Chem. 42(7), 1001–1020 (1996).
  Medline CASGoogle Scholar
• 130 Meng LJ, Griffiths WJ, Sjovall J. The identification of novel steroid N-acetylglucosaminides in the urine of pregnant women. J. Steroid Biochem. Mol. Biol. 58(5–6), 585–598 (1996).
  Medline CASGoogle Scholar
• 131 Hofmann AF. The continuing importance of bile acids in liver and intestinal disease. Arch. Intern. Med. 159(22), 2647–2658 (1999).
  Medline CASGoogle Scholar
• 132 O'byrne J, Hunt MC, Rai DK, Saeki M, Alexson SEH. The human bile acid-CoA:amino acid N-acyltransferase functions in the conjugation of fatty acids to glycine. J. Biol. Chem. 278(36), 34237–34244 (2003).
  MedlineGoogle Scholar
• 133 Krone N, Hughes BA, Lavery GG, Stewart PM, Arlt W, Shackleton CHL. Gas chromatography/mass spectrometry (GC/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC/MS/MS). J. Steroid Biochem. Mol. Biol. 121(3–5), 496–504 (2010).
  Medline CASGoogle Scholar
• 134 Mareck U, Geyer H, Opfermann G, Thevis M, Schänzer W. Factors influencing the steroid profile in doping control analysis. J. Mass Spectrom. 43(7), 877–891 (2008).
  Medline CASGoogle Scholar
• 135 Fabregat A, Pozo OJ, Marcos J, Segura J, Ventura R. Use of LC–MS/MS for the open detection of steroid metabolites conjugated with glucuronic acid. Anal. Chem. 85(10), 5005–5014 (2013).
  Medline CASGoogle Scholar
• 136 Stevenson BJ, Waller CC, Ma P et al. Pseudomonas aeruginosa arylsulfatase: a purified enzyme for the mild hydrolysis of steroid sulfates. Drug Test. Anal. 7(10), 903–911 (2015).
  Medline CASGoogle Scholar
• 137 Athanasiadou I. Chemical derivatization to enhance ionization of anabolic steroids in LC–MS for doping-control analysis. Trends Analyt. Chem. 42, 137–156 (2013).
  CASGoogle Scholar
• 138 Higashi T, Shimada K. Derivatization of neutral steroids to enhance their detection characteristics in liquid chromatography–mass spectrometry. Anal. Bioanal. Chem. 378(4), 875–882 (2004).
  Medline CASGoogle Scholar
• 139 Marcos J, Pozo OJ. Derivatization of steroids in biological samples for GC–MS and LC–MS analyses. Bioanalysis 7(19), 2515–2536 (2015).
  CASGoogle Scholar
• 140 Strahm E, Kohler I, Rudaz S et al. Isolation and quantification by high-performance liquid chromatography–ion-trap mass spectrometry of androgen sulfoconjugates in human urine. J. Chromatogr. A 1196–1197(Suppl. C), 153–160 (2008).
  Medline CASGoogle Scholar
• 141 Jänne O, Vihko R, Sjövall J, Sjövall K. Determination of steroid mono- and disulfates in human plasma. Clin. Chim. Acta 23(3), 405–412 (1969).
  Medline CASGoogle Scholar
• 142 Mckinney AR, Cawley AT, Young EB et al. The metabolism of anabolic-androgenic steroids in the greyhound. Bioanalysis 5(7), 769–781 (2013).
  CASGoogle Scholar
• 143 Marcos J, Pozo OJ. Current LC–MS methods and procedures applied to the identification of new steroid metabolites. J. Steroid Biochem. Mol. Biol. 162(Suppl. C), 41–56 (2016).
  Medline CASGoogle Scholar
• 144 Marcos J, Renau N, Casals G, Segura J, Ventura R, Pozo OJ. Investigation of endogenous corticosteroids profiles in human urine based on liquid chromatography tandem mass spectrometry. Anal. Chim. Acta 812(Suppl. C), 92–104 (2014).
  Medline CASGoogle Scholar
• 145 Pozo OJ, Van Eenoo P, Deventer K, Delbeke FT. Ionization of anabolic steroids by adduct formation in liquid chromatography electrospray mass spectrometry. J. Mass Spectrom. 42(4), 497–516 (2007).
  Medline CASGoogle Scholar
• 146 Rannulu NS, Cole RB. Novel fragmentation pathways of anionic adducts of steroids formed by electrospray anion attachment involving regioselective attachment, regiospecific decompositions, charge-induced pathways, and ion–dipole complex intermediates. J. Am. Soc. Mass. Spectrom. 23(9), 1558–1568 (2012).
  Medline CASGoogle Scholar
• 147 Pozo OJ, Van Eenoo P, Van Thuyne W, Deventer K, Delbeke FT. Direct quantification of steroid glucuronides in human urine by liquid chromatography-electrospray tandem mass spectrometry. J. Chromatogr. A 1183(1–2), 108–118 (2008).
  Medline CASGoogle Scholar
• 148 Badoud F, Boccard J, Schweizer C, Pralong F, Saugy M, Baume N. Profiling of steroid metabolites after transdermal and oral administration of testosterone by ultra-high pressure liquid chromatography coupled to quadrupole time-of-flight mass spectrometry. J. Steroid Biochem. Mol. Biol. 138(Suppl. C), 222–235 (2013).
  Medline CASGoogle Scholar
• 149 Boccard J, Badoud F, Jan N et al. Untargeted profiling of urinary steroid metabolites after testosterone ingestion: opening new perspectives for antidoping testing. Bioanalysis 6(19), 2523–2536 (2014).
  CASGoogle Scholar
• 150 Palermo A, Botre F, De La Torre X, Zamboni N. Non-targeted LC–MS based metabolomics analysis of the urinary steroidal profile. Anal. Chim. Acta 964, 112–122 (2017).
  Medline CASGoogle Scholar
• 151 Hintikka L, Kuuranne T, Aitio O, Thevis M, Schanzer W, Kostiainen R. Enzyme-assisted synthesis and structure characterization of glucuronide conjugates of eleven anabolic steroid metabolites. Steroids 73(3), 257–265 (2008).
  Medline CASGoogle Scholar
• 152 Jantti SE, Kiriazis A, Reinila RR, Kostiainen RK, Ketola RA. Enzyme-assisted synthesis and characterization of glucuronide conjugates of neuroactive steroids. Steroids 72(3), 287–296 (2007).
  MedlineGoogle Scholar
• 153 Chetwynd AJ, Samarawickrama A, Vera JH et al. Nanoflow-nanospray mass spectrometry metabolomics reveals disruption of the urinary metabolite profiles of HIV-positive patients on combination antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 74(2), e45–e53 (2017).
  Medline CASGoogle Scholar
• 154 Liang Q, Liu H, Xie L-X, Li X, Zhang A-H. High-throughput metabolomics enables biomarker discovery in prostate cancer. RSC Adv. 7(5), 2587–2593 (2017).
  CASGoogle Scholar
• 155 Boelaert J, Lynen F, Glorieux G, Schepers E, Neirynck N, Vanholder R. Metabolic profiling of human plasma and urine in chronic kidney disease by hydrophilic interaction liquid chromatography coupled with time-of-flight mass spectrometry: a pilot study. Anal. Bioanal. Chem. 409(8), 2201–2211 (2017).
  Medline CASGoogle Scholar
• 156 Luan H, Liu L-F, Meng N et al. LC–MS-based urinary metabolite signatures in idiopathic Parkinson's disease. J. Proteome Res. 14(1), 467–478 (2015).
  Medline CASGoogle Scholar
• 157 Jeanneret F, Boccard J, Badoud F et al. Human urinary biomarkers of dioxin exposure: analysis by metabolomics and biologically driven data dimensionality reduction. Toxicol. Lett. 230(2), 234–243 (2014).
  Medline CASGoogle Scholar
• 158 Singh GK, Balzer BW, Kelly PJ et al. Urinary sex steroids and anthropometric markers of puberty – a novel approach to characterising within-person changes of puberty hormones. PLoS ONE 10(11), e0143555 (2015).
  MedlineGoogle Scholar
• 159 Bufa A, Farkas N, Preisz Z et al. Diagnostic relevance of urinary steroid profiles on ovarian granulosa cell tumors: two case reports. J. Med. Case Rep. 11(1), 166 (2017).
  MedlineGoogle Scholar
• 160 Kamrath C, Wettstaedt L, Boettcher C, Hartmann MF, Wudy SA. The urinary steroidome of treated children with classic 21-hydroxylase deficiency. J. Steroid. Biochem. Mol. Biol. 165(Pt B), 396–406 (2017).
  Medline CASGoogle Scholar
• 161 Velikanova LI, Shafigullina ZR, Lisitsin AA et al. Different types of urinary steroid profiling obtained by high-performance liquid chromatography and gas chromatography-mass spectrometry in patients with adrenocortical carcinoma. Horm. Cancer 7(5–6), 327–335 (2016).
  Medline CASGoogle Scholar
• 162 Torchen LC, Idkowiak J, Fogel NR et al. Evidence for increased 5-α-reductase activity during early childhood in daughters of women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 101(5), 2069–2075 (2016).
  Medline CASGoogle Scholar
• 163 Demetrowitsch TJ, Petersen B, Keppler JK et al. Validation of a two-step quality control approach for a large-scale human urine metabolomic study conducted in seven experimental batches with LC/QTOF-MS. Bioanalysis 7(1), 103–112 (2015).
  CASGoogle Scholar
• 164 Chen Y, Xu J, Zhang R, Abliz Z. Methods used to increase the comprehensive coverage of urinary and plasma metabolomes by MS. Bioanalysis 8(9), 981–997 (2016).
  CASGoogle Scholar
• 165 García A, Godzien J, López-Gonzálvez Á, Barbas C. Capillary electrophoresis mass spectrometry as a tool for untargeted metabolomics. Bioanalysis 9(1), 99–130 (2016).
  Google Scholar
• 166 Gowda GAN, Djukovic D. Overview of mass spectrometry-based metabolomics: opportunities and challenges. Methods Mol. Biol. 1198, 3–12 (2014).
  Medline CASGoogle Scholar
• 167 Paglia G, Astarita G. Metabolomics and lipidomics using traveling-wave ion mobility mass spectrometry. Nat. Protoc. 12, 797 (2017).
  Medline CASGoogle Scholar
• 168 Zhang X, Quinn K, Cruickshank-Quinn C, Reisdorph R, Reisdorph N. The application of ion mobility mass spectrometry to metabolomics. Curr. Opin. Chem. Biol. 42(Suppl. C), 60–66 (2018).
  Medline CASGoogle Scholar